Dr. Robert Cullen Doerning, MBA, MD

Dr. Doerning practices at Harborview Medical Center in Seattle, Washington, part of University of Washington.

Dr. Doerning's NPI, 1679839260, was assigned on April 8, 2012. Dr. Doerning holds Washington license MD61273174.

Dr. Doerning's primary practice is Harborview Medical Center, at 325 9th Avenue, Seattle, WA 98104 in King County. The practice phone is (206) 744-9535.

Dr. Doerning's primary practice is Harborview Medical Center in Seattle, Washington, part of University of Washington. Dr. Doerning is also affiliated with UW Medical Center - Montlake. The medical group on file is UW Physicians. Dmand AI also links Dr. Doerning to 1 more hospital and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Doerning practices, 3 sites in all. Vendor and product names are available with a free account.

Emergency medicine is Dr. Doerning's primary specialty in the NPI Registry, under taxonomy code 207P00000X. Dr. Doerning is licensed in Washington.

CMS data shows 227 Medicare services from Dr. Doerning across 3 procedure codes in 2024, for 226 Medicare patients. Medicare paid $31,391 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 226 Medicare patients who saw Dr. Doerning in 2024. The largest group is 65 to 74, with 71 patients. 75% of them have high blood pressure, and 71% have high cholesterol. 33% are also on Medicaid. Their average risk score is 2.16, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Doerning's median patient age at 45, with 47% women.

In 2024, Dr. Doerning wrote 148 Medicare Part D claims for 88 patients. 93% of them were for generic drugs. CMS names the drug for 11 of them, across 1 drug with 11 or more claims each, at $86 in total drug cost. In 2022, CMS named 12 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Doerning for performance year 2024, reported through an alternative payment model (APM). Dr. Doerning accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 5 papers to Dr. Doerning, published from 2024 to 2025. 2025 was the busiest year, with 4. Dr. Doerning's most frequent co-authors are Matthew Stephen Shyr-Jiu Wu, MD, David J. Carlbom, MD and Christian Jordan Dameff, MD.

CMS Open Payments shows 1 general payment to Dr. Doerning from 1 drug or device company in 2024. Consulting fees make up the largest share, 100% of the total. Gilead Sciences, Inc. paid the most, $7,392.